dronabinol has been researched along with Movement Disorders in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grel, A; Metna-Laurent, M; Mondésir, M; Piazza, PV; Vallée, M | 1 |
Bender, B; Biskup, S; Hayer, SN; Schöls, L; Synofzik, M; Traschütz, A | 1 |
Bernardi, G; Cantarella, C; Cavasinni, F; Centonze, D; De Chiara, V; Furlan, R; Lo Giudice, T; Martino, G; Martorana, A; Mataluni, G; Musella, A; Muzio, L; Rossi, S | 1 |
Manzanares, J; Palomo, T; Rubio, G; Urigüen, L | 1 |
Lavie, G; Leker, RR; Ovadia, H; Shohami, E; Teichner, A | 1 |
Sassin, JF | 1 |
Englert, LF; Fritchie, GE; Ho, BT; McIsaac, WM; Taylor, D | 1 |
Chopra, GS | 1 |
2 review(s) available for dronabinol and Movement Disorders
Article | Year |
---|---|
Role of endocannabinoid system in mental diseases.
Topics: Analgesia; Animals; Brain; Cannabinoid Receptor Modulators; Cognition Disorders; Dronabinol; Endocannabinoids; Feeding Behavior; History, 20th Century; History, 21st Century; Humans; Mental Disorders; Movement Disorders; Receptor, Cannabinoid, CB1 | 2004 |
Drug-induced dyskinesia in monkeys.
Topics: Amphetamine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Azides; Carbachol; Caudate Nucleus; Chlorpromazine; Disease Models, Animal; Dronabinol; Hydroxydopamines; Levodopa; Movement Disorders; Phenothiazines; Primates; Stereotaxic Techniques; Substantia Nigra; Tegmentum Mesencephali | 1975 |
6 other study(ies) available for dronabinol and Movement Disorders
Article | Year |
---|---|
Cannabinoid-Induced Tetrad in Mice.
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Catalepsy; Disease Models, Animal; Dronabinol; Exploratory Behavior; Hypothermia; Male; Mice; Mice, Inbred C57BL; Movement Disorders; Piperidines; Pyrazoles; Rimonabant | 2017 |
TSFM mutations cause a complex hyperkinetic movement disorder with strong relief by cannabinoids.
Topics: Adult; Cannabinoid Receptor Agonists; Consanguinity; Dronabinol; Humans; Hyperkinesis; Magnetic Resonance Imaging; Male; Medical Marijuana; Mitochondrial Proteins; Movement Disorders; Peptide Elongation Factors; Subthalamic Nucleus; Young Adult | 2019 |
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis.
Topics: Animals; Antigens, CD; Corpus Striatum; Dendrites; Disease Models, Animal; Dronabinol; Encephalomyelitis, Autoimmune, Experimental; Female; Glutamic Acid; Glycoproteins; In Vitro Techniques; Mice; Mice, Inbred C57BL; Movement Disorders; Myelin-Oligodendrocyte Glycoprotein; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Peptide Fragments; Physical Conditioning, Animal; Silver Staining; Statistics, Nonparametric; Synapses; Synaptic Potentials | 2009 |
Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia.
Topics: Animals; Body Weight; Brain Ischemia; Cardiovascular Physiological Phenomena; Cerebral Cortex; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Encephalitis; Free Radicals; Infarction, Middle Cerebral Artery; Male; Movement Disorders; Nerve Degeneration; Neurons; Neuroprotective Agents; Rats; Rats, Inbred SHR; Tetrazolium Salts | 2001 |
Neuropharmacological study of 9 - and 8 -L-tetrahydrocannabinols in monkeys and mice.
Topics: Animals; Behavior, Animal; Brain; Cannabis; Cerebellum; Dronabinol; Female; Haplorhini; Hypothalamus; Medulla Oblongata; Mesencephalon; Mice; Movement Disorders; Norepinephrine; Pons; Serotonin | 1972 |
Studies on psycho-clinical aspects of long-term marihuana use in 124 cases.
Topics: Adult; Appetite; Attitude; Cannabis; Chemical and Drug Induced Liver Injury; Chronic Disease; Cognition Disorders; Dronabinol; Emotions; Humans; Inhibition, Psychological; Mental Disorders; Motivation; Movement Disorders; Nutrition Disorders; Phytotherapy; Respiratory System; Sexual Behavior; Social Behavior; Space Perception; Substance-Related Disorders; Tachycardia; Thinking; Time Factors; Time Perception | 1973 |